2019
March 27th
March 29th
Vignette
International course

5th Workshop on Dendritic Cell Biology

From Biology to the Clinic

This fifth workshop will focus on anti-tumor Immunotherapy. It consists in treating cancer by stimulating the immune system to efficiently attack tumor cells. Speakers will include internationally renowned scientists that will provide a general overview of the basic, translational, and clinical research in the field.

To apply please click HERE

 

Cours en English
Date limite d'inscription

Presentation

Objectives

The aim of this course is a better understanding of how the immune system actors including dendritic cells, detect and fight tumor cells and how their activities can be boosted.

 

Workshops

Poster presentation is optional.

Practical information

Details

Registration is free and open to all the members of the DCBIOL LabEx community (Institut Curie, Paris and CIML, Marseille), to the IMOCA industrial chair members and to international scientists and MDs working in the field (subscription of young scientists and MDs will be privileged). Students outside of the DBIOL LabEx will have to pay for flight tickets, hotel and dinners.


If you are a PALOP national working in a PALOP country (either as a researcher or medical doctor) and under 45 years old you can apply for a grant financed by Fundação Calouste Gulbenkian.

For more information, please write to joao.vilhena [at] curie.fr


The Sociedade Brasileira de Imunologia offers one travel grant: for more info and to apply, please click HERE


 

 

 

 

 

No inscription fees
Location
Champalimaud Foundation
Av. Brasília, 1400-038 Lisboa, Portugal

Max. number of

80 personnes

Participants

80

Selection criteria

A student selection will be made based on CV and motivation.

Speakers

Speakers

Bruno Santos (Instituto de Medicina Molecular - PT)

Eliane Piaggio (Institut Curie, Paris - FR)

Emanuela Romano (Institut Curie, Center for Cancer Immunotherapy, Paris - FR)

Gabriel Nuñez (University of Michigan, Sabbatical in Lisbon - PT)

Henrique Veiga-Fernandes (Champalimaud Foundation - PT)

Hidde Ploegh (Boston Children's Hospital - USA)

Julie Helft (Institut Curie, Paris - FR)

Kim Margolin (Fred Hutchinson Cancer Research Center, City of Hope - USA)

Laurie Menger (Institut Curie, Paris - FR)

Luís Moita (Instituto Gulbekian Ciência - PT)

Markus Maeurer (Champalimaud Foundation - PT)

Miguel Soares (Instituto Gulbekian Ciência - PT)

Miriam Merad (Mount Sinai Hospital, NYC - USA)

Onur Boyman (University of Zurich - CH)

Philippe Benaroch (Institut Curie, Paris - FR)

Philippe Pierre (CIML, Marseille - FR)

Pierre Guermonprez  (King's College, London - UK and Hôpital Bichat, Paris - FR)

Santiago Zelenay (Manchester University - UK)

Sebastian Amigorena (Institut Curie, Center for Cancer Immunotherapy, Paris - FR)

Vincenzo Bronte (University of Verona - IT)

Keynote speakers

Vincenzo Bronte (University of Verona - IT)

Miriam Merad (Mount Sinai Hospital, NYC - USA)

Hidde Ploegh (Boston Children's Hospital - USA)

Santiago Zelenay (Manchester University - UK)

Kim Margolin (Fred Hutchinson Cancer Research Center, City of Hope - USA)

Markus Maeurer (Champalimaud Foundation - PT)

Onur Boyman (University of Zurich - CH)

Gabriel Nuñez (University of Michigan, Sabbatical in Lisbon - PT)

Miguel Soares (Instituto Gulbekian Ciência - PT)

Organisers

DCBIOL & The Training Unit - Institut Curie

Champalimaud Foundation

Scientific Committee

Sebastian Amigorena (Institut Curie); Markus Maeurer (Champalimaud Foundation); Luís Moita (Instituto Gulbenkian Ciência); Emanuela Romano (Institut Curie) ; Bruno Santos (Instituto de Medicina Molecular); Henrique Veiga-Fernandes (Champalimaud Foundation)

With

Champalimaud Foundation

Sponsored by

Organisation

  • DCBIOL